ElMindA
Herzliya
About ElMindA
ElMindA vision is to bring a paradigm change to the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice. ElMindA has developed the BNA™ technology platform, which for the first time allows high resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain at work, capturing information on the composition, connectivity, synchronization and operation of brain networks.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $48.5M
- Funding stage: Late Stage Venture
- Last round: Grant (Mar 2019)
- Website: elminda.com
- Phone: +97248138187
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/elminda-155179 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.